Page last updated: 2024-09-02

6-hydroxydopa and Benign Neoplasms

6-hydroxydopa has been researched along with Benign Neoplasms in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Cholia, RP; Kaur, G; Kumar, R; Mantha, AK	1
Laev, SS; Lavrik, OI; Salakhutdinov, NF	1
Cavalli, A; Myers, SH; Ortega, JA	1
Andrake, M; Chandramouly, G; Glickman, JF; Kent, T; Luz, A; McDevitt, S; Pomerantz, RT; Skorski, T; Sullivan, K	1

Reviews

2 review(s) available for 6-hydroxydopa and Benign Neoplasms

Article	Year
Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1). Bioorganic & medicinal chemistry, 2017, 05-01, Volume: 25, Issue:9 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; DNA Repair; DNA-(Apurinic or Apyrimidinic Site) Lyase; Enzyme Inhibitors; Humans; Neoplasms; Oxidation-Reduction	2017
Synthetic Lethality through the Lens of Medicinal Chemistry. Journal of medicinal chemistry, 2020, 12-10, Volume: 63, Issue:23 Topics: Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cyclin-Dependent Kinases; DNA-Activated Protein Kinase; Genes, BRCA2; Humans; Neoplasms; Poly(ADP-ribose) Polymerases; Precision Medicine; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Rad51 Recombinase; Synthetic Lethal Mutations	2020

Article

Year

Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).

Bioorganic & medicinal chemistry, 2017, 05-01, Volume: 25, Issue:9

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; DNA Repair; DNA-(Apurinic or Apyrimidinic Site) Lyase; Enzyme Inhibitors; Humans; Neoplasms; Oxidation-Reduction

2017

Synthetic Lethality through the Lens of Medicinal Chemistry.

Journal of medicinal chemistry, 2020, 12-10, Volume: 63, Issue:23

Topics: Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cyclin-Dependent Kinases; DNA-Activated Protein Kinase; Genes, BRCA2; Humans; Neoplasms; Poly(ADP-ribose) Polymerases; Precision Medicine; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Rad51 Recombinase; Synthetic Lethal Mutations

2020

Other Studies

2 other study(ies) available for 6-hydroxydopa and Benign Neoplasms

Article	Year
DNA repair and redox activities and inhibitors of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1): a comparative analysis and their scope and limitations toward anticancer drug development. Journal of medicinal chemistry, 2014, Dec-26, Volume: 57, Issue:24 Topics: Antineoplastic Agents; DNA Repair; DNA-(Apurinic or Apyrimidinic Site) Lyase; Drug Design; Humans; Neoplasms; Oxidation-Reduction	2014
Small-Molecule Disruption of RAD52 Rings as a Mechanism for Precision Medicine in BRCA-Deficient Cancers. Chemistry & biology, 2015, Nov-19, Volume: 22, Issue:11 Topics: Allosteric Regulation; Apoptosis; BRCA1 Protein; BRCA2 Protein; Cell Line; Cell Proliferation; Dihydroxyphenylalanine; DNA Damage; DNA, Single-Stranded; Electrophoretic Mobility Shift Assay; Humans; Inhibitory Concentration 50; Microscopy, Fluorescence; Neoplasms; Protein Binding; Rad52 DNA Repair and Recombination Protein; Recombinant Proteins; RNA Interference; RNA, Small Interfering; Small Molecule Libraries	2015

Article

Year

DNA repair and redox activities and inhibitors of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1): a comparative analysis and their scope and limitations toward anticancer drug development.

Journal of medicinal chemistry, 2014, Dec-26, Volume: 57, Issue:24

Topics: Antineoplastic Agents; DNA Repair; DNA-(Apurinic or Apyrimidinic Site) Lyase; Drug Design; Humans; Neoplasms; Oxidation-Reduction

2014

Small-Molecule Disruption of RAD52 Rings as a Mechanism for Precision Medicine in BRCA-Deficient Cancers.

Chemistry & biology, 2015, Nov-19, Volume: 22, Issue:11

Topics: Allosteric Regulation; Apoptosis; BRCA1 Protein; BRCA2 Protein; Cell Line; Cell Proliferation; Dihydroxyphenylalanine; DNA Damage; DNA, Single-Stranded; Electrophoretic Mobility Shift Assay; Humans; Inhibitory Concentration 50; Microscopy, Fluorescence; Neoplasms; Protein Binding; Rad52 DNA Repair and Recombination Protein; Recombinant Proteins; RNA Interference; RNA, Small Interfering; Small Molecule Libraries

2015